prednisone has been researched along with Refractory Anemia in 7 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FAIGEL, HC | 1 |
| Bernini, JC | 1 |
| Carrillo, JM | 1 |
| Buchanan, GR | 1 |
| Alexandrakis, MG | 1 |
| Chatzivasili, A | 1 |
| Stefanaki, K | 1 |
| Eliopoulos, GD | 1 |
| Litvak, D | 1 |
| Kirsner, RS | 1 |
| Pakdaman, NN | 1 |
| Federman, DG | 1 |
| García Triana, Y | 1 |
| Kyle, RA | 1 |
| Stuart, RK | 1 |
| Mangan, KF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Use of Novel Therapies to Reconstitute Blood Cell Production and Promote Organ Performance Using Bone Marrow Failure as a Model: a Pilot, Phase I/II Study of the Amino Acid Leucine in the Treatment of Patients With Transfusion-Dependent Diamond Blackf[NCT01362595] | Phase 1/Phase 2 | 55 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The primary outcome is the type of response observed at 9 months. Response to treatment can be one of the following:~Complete response (CR): Hb > 9 gm/dL and transfusion-independence as defined in DBA~Partial response (PR): Hb < 9 gm/dL and increased reticulocyte count to greater than baseline.~No response (NR): no change in transfusion requirements and no significant change reticulocyte count from baseline~Progression: worsening of disease as defined by the need for more frequent transfusions" (NCT01362595)
Timeframe: 9 Months
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Complete Hematologic Response | Partial hematologic response | No hematologic response | Progression | |
| Leucine | 2 | 5 | 36 | 0 |
1 review available for prednisone and Refractory Anemia
| Article | Year |
|---|---|
Diagnosis and management of multiple myeloma and related disorders.
Topics: Alkylating Agents; Amyloidosis; Anemia; Anemia, Refractory; Animals; Antibodies, Monoclonal; Antineo | 1986 |
6 other studies available for prednisone and Refractory Anemia
| Article | Year |
|---|---|
CONGENITAL CYSTS OF THE RENAL MEDULLA. A CASE WITH SEVERE REFRACTORY ANEMIA.
Topics: Adolescent; Anemia; Anemia, Aplastic; Anemia, Refractory; Biopsy; Bone Marrow Examination; Child; Cy | 1964 |
High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone.
Topics: Adolescent; Age of Onset; Anemia, Refractory; Anti-Infective Agents; Child, Preschool; Clinical Prot | 1995 |
Co-existence of cutaneous true histiocytic lymphoma with refractory anaemia: report of a case.
Topics: Aged; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2000 |
Pyoderma gangrenosum and myelodysplastic syndrome.
Topics: Anemia, Refractory; Anemia, Sideroblastic; Bone Marrow Examination; Glucocorticoids; Hematocrit; Hum | 2000 |
[Appearance of different panmyelopathies in the same patient].
Topics: Adult; Anabolic Agents; Androgens; Anemia, Aplastic; Anemia, Refractory; Hemoglobinuria, Paroxysmal; | 1992 |
Hematologic and cytogenetic remission of 5q-refractory anemia after syngeneic bone marrow transplantation.
Topics: Adult; Anemia, Refractory; Blood Transfusion; Bone Marrow Transplantation; Chromosome Aberrations; C | 1986 |